NSTE-ACS patients have lower initial mortality but comparable or higher long-term mortality compared to STE-ACS patients, highlighting the importance of optimal management strategies.
Acute coronary syndromes (ACS) continue to represent a major cause of morbidity and mortality worldwide. In the past decade data from the United States and Europe reported decreased incidence of ST-elevation myocardial infarction (STE-ACS) with an increase in non-ST-elevation myocardial infarction (NSTE-ACS). As compared to STE-ACS patients, during initial admission, NSTE-ACS patients are at lower risk for death, but over time death rates become comparable with a trend towards increased mortality in the latter group. NSTE-ACS therefore constitutes a challenge in cardiology.
No takes yet. Share an insight, caveat, or question.
Navarese et al. (2018) conducted an editorial in Non-ST elevation myocardial infarction (NSTE-ACS). Timing of coronary invasive approach was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: